Newsletter

Report adverse event
SmPC

Sweden
Bulgaria
CZECH REPUBLIC
Denmark
Finland
International
Latvia
Netherlands
Norway
Poland
Russia
Serbia
Slovakia
Slovenia
Spain
Ukraine

Schizophrenia
About REAGILA
- Mode of Action
  - The Mechanism of Action of REAGILA
- Clinical Data
  - Efficacy
  - Safety
Prescribing REAGILA
Education & Resources
Events

Visit this section

Schizophrenia
About REAGILA
- Mode of Action
  - The Mechanism of Action of REAGILA
- Clinical Data
  - Efficacy
  - Safety
Prescribing REAGILA
Education & Resources
Events

Report adverse event
SmPC

Sweden
Bulgaria
CZECH REPUBLIC
Denmark
Finland
International
Latvia
Netherlands
Norway
Poland
Russia
Serbia
Slovakia
Slovenia
Spain
Ukraine

website for members of the public

Healthcare professionals

Subscribe to the schizophrenialife.se newsletter to receive news about new site content, schizophrenia and Reagila. You will have the right to unsubscribe at any time.

Title

Name

Clinic

Country

Email

Newsletter Permissions

RECORDATI AB saves your personal Information In order to update you in the field of schizophrenia. We will not share the data with any third party. You can request Information at any time aboutwhat Information is registered about you and request correctlon or deletion of the Information bycontacting us by mail, RECORDATIAB, Jan Stenbecks Torg 17, 16440 Kista, or e-mail (infonordic@recordati.com).

You can unsubscribe any time by clicking on the link in the footer of our newsletters and emails. For information on how your data will be stored and used, please read the schizophrenialife.se privacy policy below.

Schizophrenialife.se Privacy Policy

THIS WEBSITE CONTAINS INFORMATION ON REAGILA (CARIPRAZINE) WHICH IS BASED ON THE SUMMARY OF PRODUCT CHARACTERISTICS (SMPC). THIS WEBSITE IS INTENDED TO PROVIDE INFORMATION EXCLUSIVELY TO HEALTHCARE PROFESSIONALS IN THE EUROPEAN UNION AND NOT INTENDED FOR AUDIENCE IN THE US OR CANADA. IF YOU ARE NOT A HEALTHCARE PROFESSIONAL, PLEASE LEAVE THE PAGE AND CONTACT A HEALTHCARE PROFESSIONAL.

Privacy Policy
Cookie Policy
Terms of use
Contact Us

This website was last reviewed/updated October 2021

© 2020 Recordati

This website is intended for Healthcare Professionals only

Please confirm that you are a Healthcare professional.

You are now leaving the site and will be re-directed to an external website.

Accept

Cancel

Showing 0 result(s).

Please log in to see 0 more result(s).

Subscribe to the schizophrenialife.se newsletter to receive news about new site content, schizophrenia and Reagila. You will have the right to unsubscribe at any time.

Title

Name

Clinic

Country

Email

Newsletter Permissions

RECORDATI AB saves your personal Information In order to update you in the field of schizophrenia. We will not share the data with any third party. You can request Information at any time aboutwhat Information is registered about you and request correctlon or deletion of the Information bycontacting us by mail, RECORDATIAB, Jan Stenbecks Torg 17, 16440 Kista, or e-mail (infonordic@recordati.com).

You can unsubscribe any time by clicking on the link in the footer of our newsletters and emails. For information on how your data will be stored and used, please read the schizophrenialife.se privacy policy below.